Clinical trials: Hemorrhagic Cystitis

BK Virus Infection, Hemorrhagic Cystitis

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

• Terminated
• Age: 1 year and older
• Phase 3
• Results posted

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC).

Trial name

NCT04390113

Testing

Posoleucel (ALVR105)

Where

56 sites in United States, France and 5 more

Volunteers

97 people

Sponsor

AlloVir